Home/Filings/4/0000899243-17-018102
4//SEC Filing

AILERON THERAPEUTICS INC 4

Accession 0000899243-17-018102

$RNTXCIK 0001420565operating

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 8:24 PM ET

Size

20.7 KB

Accession

0000899243-17-018102

Insider Transaction Report

Form 4
Period: 2017-07-05
Transactions
  • Conversion

    Common Stock

    2017-07-05+18,77119,022 total
  • Conversion

    Common Stock

    2017-07-05+1,780,5641,799,586 total
  • Conversion

    Series C-2 Preferred Stock

    2017-07-054,238,6070 total
    Common Stock (426,547 underlying)
  • Conversion

    Series A Preferred Stock

    2017-07-051,250,0000 total
    Common Stock (12,579 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2017-07-05615,3840 total
    Common Stock (6,192 underlying)
  • Conversion

    Series B Preferred Stock

    2017-07-053,706,0560 total
    Common Stock (372,955 underlying)
  • Conversion

    Series C-1 Preferred Stock

    2017-07-052,967,0250 total
    Common Stock (298,583 underlying)
  • Conversion

    Series D Preferred Stock

    2017-07-056,781,7700 total
    Common Stock (682,476 underlying)
Footnotes (3)
  • [F1]The Series A and Series A-1 Preferred Stock converted into Common Stock on a 99.37-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and A-1 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering.The shares had no expiration date.
  • [F2]The Series B, Series C-1, Series C-2 and Series D Preferred Stock converted into Common Stock on a 9.937-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C-1, Series C-2 and Series D Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F3]Dr. Seth L. Harrison is a principal of the general partner of Apple Tree Partners II, L.P., and Dr. Harrison disclaims beneficial ownership of the shares held by Apple Tree Partners II, L.P., except to the extent of his pecuniary interest therein. Dr. Harrison has sole voting and investment power over the shares held by Apple Tree Partners II, L.P.

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeoperating

Related Parties

1
  • filerCIK 0001420565

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 8:24 PM ET
Size
20.7 KB